A hospital's clinical toxicology service is reviewing protocols for the acute management o… — USMLE Step 2 CK

A hospital's clinical toxicology service is reviewing protocols for the acute management of various hazardous ingestions and exposures. For each patient presentation described below, match the clinical scenario and associated findings with the most appropriate specific pharmacological intervention.

A young adult presents with severe psychomotor agitation, diaphoresis, mydriasis, and a blood pressure of $185/110\text{ mmHg}$ . Electrocardiogram shows sinus tachycardia.Administration of intravenous benzodiazepines
An older adult presents with profound bradycardia, hypotension, diffuse wheezing, and altered mental status. Capillary blood glucose is $48\text{ mg/dL}$ .Administration of intravenous glucagon
An older adult presents with nausea, vomiting, confusion, and a yellow tint to their vision. Laboratory testing reveals a serum potassium concentration of $6.4\text{ mEq/L}$ .Administration of digoxin-specific antibody fragments
An agricultural worker presents with copious salivation, bronchospasm, pinpoint pupils, and diffuse muscle fasciculations. Heart rate is $45\text{ /min}$ .Administration of intravenous atropine followed by pralidoxime

Answer

Match the sympathomimetic toxidrome with intravenous benzodiazepines, the beta-blocker toxicity with intravenous glucagon, the digoxin toxicity with digoxin-specific antibody fragments, and the cholinergic toxidrome with intravenous atropine followed by pralidoxime.

Each clinical scenario outlines a classic pattern of intoxication that corresponds to a unique and targeted pharmacological intervention. Recognizing the distinct pattern of vital sign derangements (e.g., bradycardia vs. tachycardia), pupillary changes (e.g., miosis vs. mydriasis), and specific metabolic abnormalities (e.g., hypoglycemia, hyperkalemia) allows for rapid selection of the correct antidote.

Step-by-Step Solution

Analyze the first clinical presentation for key toxidrome features.

Identify a sympathomimetic toxidrome, requiring central sympathetic inhibition.

Benzodiazepines are the safest and most effective first-line agents for sympathomimetic-induced cardiovascular and central nervous system hyperactivity.

Analyze the second clinical presentation for key toxidrome features.

Identify beta-blocker toxicity (manifested by bradycardia, wheezing, and hypoglycemia), requiring receptor-independent inotropy.

Glucagon bypasses the blocked beta-receptors to directly activate adenylate cyclase in myocardial tissue.

Analyze the third clinical presentation for key toxidrome features.

Identify severe digoxin toxicity complicated by life-threatening hyperkalemia, requiring specific drug neutralization.

Digoxin-specific antibody fragments are definitively indicated for digoxin toxicity when accompanied by severe hyperkalemia or life-threatening arrhythmias.

Analyze the fourth clinical presentation for key toxidrome features.

Identify a cholinergic toxidrome (organophosphate poisoning), requiring both muscarinic and nicotinic reversal.

Atropine blocks the life-threatening muscarinic effects (such as bronchorrhea and bradycardia), while pralidoxime addresses the nicotinic effects (such as muscle fasciculations) by reactivating the inhibited cholinesterase enzyme.

Key Concept

Recognition of classic toxicological syndromes (toxidromes) based on vital sign derangements, pupillary findings, and specific laboratory abnormalities is essential for the timely administration of targeted, life-saving antidotes.

Question

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Topics

More questions from this topic